Purpose: This study aimed to correlate the predictive values of geometrical sparing factors of rectum and bladder in high-dose-rate intracavitary brachytherapy (HDRICB) after uniform external beam radiotherapy with late sequelae in patients with uterine cervical cancer.
Methods: From September 1992 to December 1998, 154 patients who survived more than 12 months after treatment were studied. Initially, they were treated with 10 MV X-rays (44 to 45 Gy/22 to 25 fractions over 4 to 5 weeks) to the whole pelvis, after which HDRICB was performed using Ir-192 remote after-loading at 1-week intervals for 4 weeks. The standard prescribed dose for each HDRICB was 6.0 Gy to point A. Geometrical sparing factor (GSF) is defined as the ratio between reference doses in HDRICB and point A dose, whereas biological GSF is modified by using a linear-quadratic model. Patient and treatment related factors were evaluated for late rectal complications using Student's t-test and chi-square test.
Result: The probability of rectal complications shows better correlation with increasing biological GSF. If the biological rectal GSF was less than 0.6, the probability of rectal complication did not exceed 20%, while the biological bladder GSF was less than 0.8, the probability of bladder complication did not exceed 10%. The analysis demonstrated a high risk of late rectal sequelae in patients who developed bladder complications (
p =0.0001, relative risk, 15.6) and biological rectal GSF>0.6 (
p =0.02, relative risk, 2.08). The high risk factors for bladder complications were patients who developed rectal complications (
p =0.0001, relative risk, 15.2) and biological bladder GSF>0.8 (
p =0.04, relative risk, 2.85).
Conclusion: This study demonstrated the predictive value of rectal and bladder GSF in HDRICB for patients receiving uniform EBRT. Patients who had higher biological GSFs were at risk of late sequelae. Further study is imperative to delineate the close relationship between rectal and bladder complications.
View full abstract